TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26336919

Group type: EXPERIMENTAL
Intervention: Intravenous sodium bicarbonate (3 ml/kg/h for 1 h; n = 43)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Oral sodium citrate (75 ml/10 kg divided into 4 doses; n = 43)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Nonspecific hydration (n = 44)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 130
Study: 24252587

Group type: EXPERIMENTAL
Intervention: Grief-Help (cognitive behavioural treatment) combined with five sessions of parental counselling
Number of subjects: 160

Group type: COMPARATOR
Intervention: Supportive counselling combined with five sessions of parental counselling
Number of subjects: 160
Study: 21262791

Group type: EXPERIMENTAL
Intervention: Waterlow screening tool (n=410)
Number of subjects: 1231

Group type: EXPERIMENTAL
Intervention: Ramstadius screening tool (n=411)
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Clinical judgement (n=410)
Number of subjects: 1231
Study: 18768432

Group type: EXPERIMENTAL
Intervention: Depot octreotide (100 microg subcutaneously on day 1, followed by 20 mg intramuscularly on days 2 and 29)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Depot octreotide
Number of subjects: 125
Study: 17137546

Group type: EXPERIMENTAL
Intervention: Antibiotics (oral trimethoprim-sulfamethoxazole, amoxicillin, or doxycycline)
Number of subjects: 917

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 917

Group type: COMPARATOR
Intervention: Amoxicillin (7 days)
Number of subjects: 917
Study: 12703393

Group type: EXPERIMENTAL
Intervention: Focused videotape instruction in the clinic (n = 106)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control (no instruction in the clinic waiting area) (n = 109)
Number of subjects: 215
Study: 10720524

Group type: EXPERIMENTAL
Intervention: Pertussis toxoid vaccination
Number of subjects: 813
Study: 9370552

Group type: EXPERIMENTAL
Intervention: ProHance administered at doses ranging from 0.1 mmol/kg to 0.3 mmol/kg
Number of subjects: 2656

Group type: EXPERIMENTAL
Intervention: ProHance at a higher dose level of 0.3 mmol/kg
Number of subjects: 2656
Study: 1383099

Group type: EXPERIMENTAL
Intervention: Octreotide (100 micrograms) administered intravenously five minutes before ERCP and subcutaneously 45 minutes after ERCP
Number of subjects: 245

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Therapeutic interventions
Number of subjects: 245
Study: 31828089

Group type: EXPERIMENTAL
Intervention: Lower extremity motor control exercises added to the standard rehabilitation program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard rehabilitation program
Number of subjects: 32
Study: 29523800

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid neurogranin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid TREM2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Age adjustment for TREM2
Number of subjects: 0
Study: 26209090

Group type: EXPERIMENTAL
Intervention: GC rs2282679 genotype
Number of subjects: 702
Study: 25260889

Group type: EXPERIMENTAL
Intervention: Alcaftadine 0.25%
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.2%
Number of subjects: 284
Study: 22961907

Group type: EXPERIMENTAL
Intervention: Bilberry diet (400 g fresh bilberries daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control diet (habitual diet)
Number of subjects: 27
Study: 30178742

Group type: EXPERIMENTAL
Intervention: Voglibose plus metformin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Individual voglibose and metformin tablets
Number of subjects: 30

Group type: COMPARATOR
Intervention: Voglibose alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Individual voglibose and metformin tablets and FDC
Number of subjects: 30
Study: 17559845

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance during embryo transfer
Number of subjects: 5968

Group type: COMPARATOR
Intervention: Clinical touch method
Number of subjects: 5968
Study: 16549926

Group type: EXPERIMENTAL
Intervention: Radiofrequency sinus excision (RSE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Wide excision and healing by open granulation procedure (WEG)
Number of subjects: 44
Study: 12399264

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other dietary oils (palm oil, safflower oil, fish and safflower oil mixture)
Number of subjects: 0
Study: 9973874

Group type: EXPERIMENTAL
Intervention: Articulated balance arm
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Pneumatic hoist
Number of subjects: 4

Group type: COMPARATOR
Intervention: Manual lifting
Number of subjects: 4
Study: 8643018

Group type: EXPERIMENTAL
Intervention: Plasmapheresis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dosed intravenous immunoglobulins (0.4 g/kg/daily for five days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids (500 mg methylprednisolone daily for five days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment with high dose methylprednisolone and immunoglobulins
Number of subjects: 0

Group type: COMPARATOR
Intervention: General medical care and supportive therapy in the intensive care unit
Number of subjects: 0
Study: 2197003

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazemuls (diazepam in oil emulsion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups received fentanyl 0.5 micrograms.kg‐1 IV
Number of subjects: 60
Study: 7022706

Group type: EXPERIMENTAL
Intervention: Single dose carbenicillin prophylaxis preoperatively
Number of subjects: 50

Group type: COMPARATOR
Intervention: T-tube suction drainage postoperatively
Number of subjects: 50
Study: 31794130

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: nicardipine
Number of subjects: 131

Group type: COMPARATOR
Intervention: NaCl
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Ca+ channel blocker (verapamil or nicardipine)
Number of subjects: 131
Study: 27729394

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no exercise program)
Number of subjects: 86
Study: 25885818

Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressants
Number of subjects: 0
Study: 23989522

Group type: EXPERIMENTAL
Intervention: 4 mg/kg/day prednisolone (group A, n = 35)
Number of subjects: 69

Group type: COMPARATOR
Intervention: 2 mg/kg/day prednisolone (group B, n = 34)
Number of subjects: 69
Study: 21052886

Group type: COMPARATOR
Intervention: Group counseling (n=21)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Individual consultation (n=22)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control arm (n=24)
Number of subjects: 67
Study: 19996400

Group type: EXPERIMENTAL
Intervention: Inhaled oxygen at 100%, 12 L/min, delivered by face mask for 15 minutes.
Number of subjects: 109

Group type: COMPARATOR
Intervention: High-flow air placebo delivered alternately for 4 attacks.
Number of subjects: 109
Study: 17471214

Group type: EXPERIMENTAL
Intervention: PDA use
Number of subjects: 12
Study: 15588478

Group type: EXPERIMENTAL
Intervention: Sample size and marker set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marker set
Number of subjects: 0
Study: 11283037

Group type: EXPERIMENTAL
Intervention: ViroSeq HIV-1 Genotyping System
Number of subjects: 196
Study: 9399720

Group type: EXPERIMENTAL
Intervention: Electrophysiologic testing with highly reproducible arrhythmias
Number of subjects: 473

Group type: COMPARATOR
Intervention: Electrophysiologic testing with less reproducible arrhythmias
Number of subjects: 473
Study: 7955184

Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 151
Study: 2821808

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g four times a day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Alginate/antacid compound (5 g four times a day)
Number of subjects: 50
Study: 30668179

Group type: EXPERIMENTAL
Intervention: Topical 10% Potassium hydroxide (KOH) gel applied once daily up to clearing (maximum 30 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical 10% Potassium hydroxide (KOH) gel
Number of subjects: 0
Study: 27350144

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A injection in the medial orbicularis muscle of the lower eyelid
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A injection
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (sham group)
Number of subjects: 20
Study: 26153128

Group type: EXPERIMENTAL
Intervention: atrasentan 0.75 mg/d
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: atrasentan 1.25 mg/d
Number of subjects: 211

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: atrasentan (both doses)
Number of subjects: 211
Study: 23759268

Group type: EXPERIMENTAL
Intervention: Glucomannan
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 21148531

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (TIV)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 506
Study: 19926006

Group type: EXPERIMENTAL
Intervention: Remote monitoring (pacemaker information transmitted at 3-month intervals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (transtelephonic monitoring with office visits)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (transtelephonic monitoring)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remote monitoring
Number of subjects: 0
Study: 16421658

Group type: EXPERIMENTAL
Intervention: Self-administered format (SA)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Parent and adolescent group format (PAG)
Number of subjects: 225
Study: 15474212

Group type: EXPERIMENTAL
Intervention: Tall Man letters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard drug names
Number of subjects: 0
Study: 11298617

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Open appendicectomy
Number of subjects: 61
Study: 9247610

Group type: EXPERIMENTAL
Intervention: Carboplatin administered on a single-day schedule
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Carboplatin administered on a 5-day schedule
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Calvert's formula for dosing carboplatin
Number of subjects: 11
Study: 8320627

Group type: EXPERIMENTAL
Intervention: Zinc sulfate 5 mg/kg per day for 6 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Untreated children (control group)
Number of subjects: 21
Study: 2446758

Group type: EXPERIMENTAL
Intervention: Isoprinosine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Chlorambucil
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 29230686

Group type: EXPERIMENTAL
Intervention: Breast cancer educational program (1-day program with theoretical and practical sessions)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110
Study: 28219367

Group type: EXPERIMENTAL
Intervention: Pharmacist-delivered structured smoking cessation program (4 sessions at 2 to 4 week intervals)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Pharmacist-delivered structured smoking cessation program
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control group (unstructured brief smoking cessation counseling)
Number of subjects: 314
Study: 25249429

Group type: EXPERIMENTAL
Intervention: Size 3 ProSeal™ laryngeal mask airway (PLMA)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Size 4 ProSeal™ laryngeal mask airway (PLMA)
Number of subjects: 152
Study: 24660233

Group type: EXPERIMENTAL
Intervention: Ivacaftor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21081776

Group type: EXPERIMENTAL
Intervention: Aprepitant 40 mg with dexamethasone 10 mg
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ondansetron 4 mg IV with dexamethasone 10 mg
Number of subjects: 104
Study: 20071893

Group type: EXPERIMENTAL
Intervention: Early nursing intervention program (home visits every two weeks for three months)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 42
Study: 17376581

Group type: EXPERIMENTAL
Intervention: PDA providing visual and audio instructions
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group without the PDA
Number of subjects: 101
Study: 15525294

Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day for 24 months (total exposure up to 36 months)
Number of subjects: 0
Study: 11336137

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation through red palm oil (RPO) for 10 months
Number of subjects: 755
Study: 10086898

Group type: COMPARATOR
Intervention: L-thyroxine supplementation (placebo group)
Number of subjects: 50
Study: 7843446

Group type: EXPERIMENTAL
Intervention: Group II (hyperprolactinemia) with PRL > 20 ng/mL
Number of subjects: 49

Group type: COMPARATOR
Intervention: Group I (control) with PRL ≤ 20 ng/mL
Number of subjects: 49
Study: 2520495

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 836010

Group type: EXPERIMENTAL
Intervention: Intravenous administration of amoxicillin (250 mg, 500 mg, 1000 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral administration of amoxicillin (250 mg, 500 mg, 1000 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of amoxicillin (250 mg, 500 mg, 1000 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular and oral administration of amoxicillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total absorption of amoxicillin (via urinary recovery and AUC)
Number of subjects: 0
Study: 30914100

Group type: EXPERIMENTAL
Intervention: New modified sick clothes
Number of subjects: 408
Study: 28900370

Group type: EXPERIMENTAL
Intervention: Routine laboratory preoperative tests (POTs)
Number of subjects: 1129
Study: 25844854

Group type: EXPERIMENTAL
Intervention: Power-stability-training group (PS group)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Traditional endurance-training group (ET group)
Number of subjects: 46
Study: 23703915

Group type: EXPERIMENTAL
Intervention: Arthroscopic meniscectomy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Nonoperative treatment with strengthening exercises
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study: 23117648

Group type: EXPERIMENTAL
Intervention: Proprioceptive exercises added to stretching and strengthening exercises and cryotherapy (Group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching and strengthening exercises and cryotherapy (Group 1, Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 0
Study: 19411662

Group type: EXPERIMENTAL
Intervention: tolvaptan (vasopressin antagonist)
Number of subjects: 4133

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 4133
Study: 17716313

Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD; 20 mg bid)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 15222726

Group type: EXPERIMENTAL
Intervention: Test formulation (10 mg generic amlodipine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference formulation (10 mg amlodipine)
Number of subjects: 0
Study: 11486923

Group type: EXPERIMENTAL
Intervention: Blocked practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomly interleaved practice
Number of subjects: 0
Study: 9772954

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 5461

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 5461
Study: 8153803

Group type: EXPERIMENTAL
Intervention: Standard work tolerance program plus exercise on the B‐200 Isostation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard work tolerance program only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (volunteers with neither back pain nor known underlying spinal pathology)
Number of subjects: 0
Study: 2646004

Group type: EXPERIMENTAL
Intervention: CFPT (Cyclophosphamide, 5-Fluorouracil, Prednisone + Tamoxifen)
Number of subjects: 400

Group type: COMPARATOR
Intervention: CFP (Cyclophosphamide, 5-Fluorouracil, Prednisone)
Number of subjects: 400
Study: 1092398

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31897731

Group type: EXPERIMENTAL
Intervention: Automated vertebral segmentation method using fine-tuned Mask R-CNN
Number of subjects: 428
Study: 31034311

Group type: EXPERIMENTAL
Intervention: Low Intensity Resistance Exercise Training (LIRET)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 20
Study: 28125970

Group type: EXPERIMENTAL
Intervention: Personal online coaching based on identified nutrition and lifestyle risk factors, with a maximum of three messages per week.
Number of subjects: 0

Group type: COMPARATOR
Intervention: One recipe per week to maintain adherence to the program.
Number of subjects: 0
Study: 25592201

Group type: EXPERIMENTAL
Intervention: Waste the Waist intervention (9 sessions)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual care and standardised information on cardiovascular risk and lifestyle (Controls)
Number of subjects: 108
Study: 22865017

Group type: EXPERIMENTAL
Intervention: Three Component Model (3CM)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 195
Study: 22315776

Group type: EXPERIMENTAL
Intervention: Hypertensive group (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normotensive group (Group B)
Number of subjects: 60
Study: 19919399

Group type: EXPERIMENTAL
Intervention: Resperate device-guided breathing exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (listened to music)
Number of subjects: 30
Study: 17545892

Group type: EXPERIMENTAL
Intervention: Liquid carbohydrate (CHO) (200 mL.h, 20% CHO (40 g.h, 160 kcal.h))
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Liquid CHO (200 mL.h, 20% CHO (40 g.h, 160 kcal.h)) every even hour and solid CHO (25 g of CHO, 10 g of protein, 2 g of fat, and 160 kcal.h) every odd hour
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Shift food items of approximately 150‐400 kcal at 90‐min intervals after breakfast
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sack lunch
Number of subjects: 76
Study: 15139984

Group type: EXPERIMENTAL
Intervention: HIV/HCV coinfection prevalence
Number of subjects: 1649

Group type: EXPERIMENTAL
Intervention: Predictors of HIV/HCV coinfection
Number of subjects: 1649

Group type: EXPERIMENTAL
Intervention: Predictive values for HIV/HCV coinfection
Number of subjects: 1649

Group type: COMPARATOR
Intervention: HIV disease progression
Number of subjects: 1649

Group type: EXPERIMENTAL
Intervention: Prevalence of HIV/HCV coinfection among homosexual men
Number of subjects: 1649
Study: 11488319

Group type: EXPERIMENTAL
Intervention: Repeated low-dose allergen exposure
Number of subjects: 0
Study: 9791040

Group type: EXPERIMENTAL
Intervention: Neutral endopeptidase inhibitor (SCH 32615, 200 mg intravenously)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle alone (control group)
Number of subjects: 24
Study: 7922474

Group type: EXPERIMENTAL
Intervention: LSD (letter-sound training)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: OR (onset-rhyme training)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: WW (whole word training)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Math-training control program
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All literacy-training groups
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LSD-trained subjects
Number of subjects: 22
Study: 3279774

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus vancomycin
Number of subjects: 470

Group type: COMPARATOR
Intervention: Piperacillin plus vancomycin
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Piperacillin plus ceftazidime and vancomycin
Number of subjects: 470
Study: 31984443

Group type: EXPERIMENTAL
Intervention: Insulin degludec 200 U/ml (degludec U200)
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Insulin glargine 300 U/ml (glargine U300)
Number of subjects: 1609
Study: 31644511

Group type: EXPERIMENTAL
Intervention: UE videolaryngoscopy
Number of subjects: 440

Group type: COMPARATOR
Intervention: Macintosh's direct laryngoscopy
Number of subjects: 440
Study: 29949479

Group type: EXPERIMENTAL
Intervention: 40-minute application of 38% hydrogen peroxide bleaching agent
Number of subjects: 44

Group type: COMPARATOR
Intervention: Two 20-minute applications of 38% hydrogen peroxide bleaching agent
Number of subjects: 44
Study: 27351245

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24439637

Group type: EXPERIMENTAL
Intervention: High frequency TENS treatment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham TENS treatment
Number of subjects: 55
Study: 22585692

Group type: EXPERIMENTAL
Intervention: bortezomib-thalidomide-dexamethasone (VTD)
Number of subjects: 269

Group type: COMPARATOR
Intervention: thalidomide-dexamethasone (TD)
Number of subjects: 269
Study: 19712802

Group type: EXPERIMENTAL
Intervention: Testosterone (intramuscular injection every 6 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 17961387

Group type: EXPERIMENTAL
Intervention: 90 s freezing intercostal nerves with PCIA
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 90 s freezing intercostal nerves
Number of subjects: 150

Group type: COMPARATOR
Intervention: 60 s freezing intercostal nerves
Number of subjects: 150

Group type: COMPARATOR
Intervention: PCIA
Number of subjects: 150
Study: 15223252

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (i.v.IG)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11259862

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg for two days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12